Predictors of Bleeding Evaluation in Adult Hematologic Patients with Bleeding Tendencies Patients with established bleeding disorders: The BePa verification study

Predictors of Bleeding Evaluation in Adult Hematologic Patients with Bleeding Tendencies Patients with established bleeding disorders: The BePa verification study - BePa study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53063

Enrollment

140

Registered

2014-12-15

Start date

2015-10-22

Completion date

Unknown

Last updated

2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhagic diathesis

Interventions

none

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Age => 18 years Signed informed consent

Exclusion criteria

Exclusion criteria: Pregnancy (or lactating); Active bleeding due to medical interventions or surgical/obstetrical causes Use of any interfering medicatie

Design outcomes

Primary

Measure	Time frame
Diagnostic parameters such as sensitivity, specificity, likelihood ratios and AUC with 95% confidence intervals of the experimental haemostatic tests for detection of a bleeding disorder.	—

Secondary

Measure	Time frame
Changes in experimental test results before and after prophylactic medication within patients with bleeding disorders who receive prophylactic medication. These changes will be compared to changes in plasma factor levels to evaluate whether experimental tests can detect normalisation/increase of coagulant factor levels.	—

Countries

Netherlands

Contacts

Public ContactFCJI Heubel-Moenen

Maastricht Universitair Medisch Centrum +

floor.moenen@mumc.nl0614446151

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)